Holen Sie sich die Stockscreener-App
351.85
0.82%
2.85
Handel nachbörslich:
351.85
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
FDA Warns Of Fatal Liver Risks Linked To Amgen Tavneos UseAmgen (NASDAQ:AMGN) - Benzinga
US FDA warns of liver injury cases tied to Amgen's rare disease drug - Reuters
FDA Says Amgen’s Tavneos Linked to Liver Injuries, Deaths - WSJ
FDA Flags Serious Liver Risks with Amgen's Tavneos (AMGN) - GuruFocus
FDA issues warning for Amgen's Tavneos following serious liver injury cases - Seeking Alpha
Amgen CEO Bob Bradway's 2025 Letter to Shareholders - Amgen
Amgen’s Tavneos Associated With Liver Injury, Deaths, FDA Says - Bloomberg.com
Amgen price breaches upside trend lineForecast tody31-03-2026 - Economies.com
Amgen Inc. $AMGN Shares Purchased by Hofer & Associates. Inc - MarketBeat
The Zacks Analyst Blog Roche Holding, AT&T and Amgen - The Globe and Mail
Mn Services Vermogensbeheer B.V. Acquires 3,327 Shares of Amgen Inc. $AMGN - MarketBeat
Financial Planning Hawaii Inc. Takes Position in Amgen Inc. $AMGN - MarketBeat
Brookstone Capital Management Purchases 3,098 Shares of Amgen Inc. $AMGN - MarketBeat
Top Stock Reports for Roche, AT&T & Amgen - The Globe and Mail
Jefferies reiterates Amgen stock Hold rating on TED trial data - Investing.com
Amgen Inc. Stock: Steady Biotech Leader with Strong Dividend Yield and Growth Guidance Amid Analyst - AD HOC NEWS
Amgen’s Repatha Slashes Heart Event Risk in Early‑Stage Patients - Citeline News & Insights
Teva gagne du terrain dans le domaine des médicaments biosimilaires grâce à l’approbation accordée par la FDA pour PONLIMSI™ (dénosumab-adet) et à l’acceptation d’un double dossier pour un candidat biosimilaire à Xolair® (omalizumab) - GlobeNewswire Inc.
Amgen (AMGN) Stock Up Since Jim Cramer Said “You Could Do a Lot Worse Than Amgen” - Insider Monkey
R.H. Dinel Investment Counsel Inc. Has $6.33 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Exchange Traded Concepts LLC Reduces Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (AMGN): Billionaire Ken Fisher doubles bullish position - MSN
Here's What You Need to Know about Amgen, Inc's AMG-145 - Yahoo
Amgen Inc. $AMGN Shares Bought by Wealthcare Advisory Partners LLC - MarketBeat
Nova R Wealth Inc. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen’s Repatha Data Reinforces Cardiovascular Franchise And Valuation Debate - simplywall.st
Amgen's Repatha Cuts Risk Of First Major Cardiovascular Event By 31% In High-Risk Patients - TradingView
In diabetes patients, Repatha cut first major heart event risk 31% - stocktitan.net
Amgen Inc. stock underperforms Friday when compared to competitors - MarketWatch
Here is what to know beyond why Amgen Inc. (AMGN) is a trending stock - MSN
Anti-Cancer MAbS Market Report 2026-2030 Featuring - GlobeNewswire
Anti-Cancer MAbS Market Report 2026-2030 Featuring Strategic Analysis of Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, Roche, GlaxoSmithKline and Other Key Players - Yahoo Finance
Amgen stock consolidates as leaders tout AI in medicine discovery and delivery - Traders Union
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - Yahoo Finance
Global X Japan Co. Ltd. Has $6.80 Million Position in Amgen Inc. $AMGN - MarketBeat
Dakota Wealth Management Acquires 4,581 Shares of Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation As Shares Show Mixed Short And Long Term Returns - simplywall.st
AMGN Stock Price, Quote & Chart | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen stock moves lower after Rep Luz Rivas joins Amgen Foundation students - Traders Union
Vanguard Group reports zero Amgen (AMGN) holdings after internal realignment - stocktitan.net
Amgen Inc. Stock: Steady Biotech Leader with Strong Dividend Yield and Institutional Backing for Nor - AD HOC NEWS
National Wealth Management Group LLC Makes New $1.53 Million Investment in Amgen Inc. $AMGN - MarketBeat
FY2027 EPS Estimates for Amgen Increased by Erste Group Bank - MarketBeat
Ferguson Wellman Capital Management Inc. Has $102.76 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by Czech National Bank - MarketBeat
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Amgen Named One of the 2026 World’s Most Ethical Companies® by Ethisphere - Amgen
Amgen Named One of the World’s Most Ethical Companies® by Ethisphere - Amgen
Amgen’s Rocatinlimab Trial Completion Signals Next Phase for Atopic Dermatitis Strategy - TipRanks
Wells Fargo raises its price target on Amgen (AMGN) to $390 from $375 - MSN
Wells Fargo Raises its Price Target on Amgen (AMGN) to $390 from $375 - Insider Monkey
Pensionfund Sabic Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Assenagon Asset Management S.A. Sells 59,138 Shares of Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation After Recent Share Price Pullback And Mixed Short Term Returns - Yahoo Finance
SG Americas Securities LLC Acquires 113,909 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by E. Ohman J or Asset Management AB - MarketBeat
Clear Trail Advisors LLC Takes Position in Amgen Inc. $AMGN - MarketBeat
Avanza Fonder AB Increases Holdings in Amgen Inc. $AMGN - MarketBeat
Lilly, Amgen Seek Fast Win in Suit Over Clinics in Discount Plan - Bloomberg Law News
The Genetic Puzzle of Heart Disease: Inside Amgen’s Commitment to Lp(a) - Amgen
Marshall Financial Group LLC Purchases New Position in Amgen Inc. $AMGN - MarketBeat
180 Wealth Advisors LLC Acquires 6,535 Shares of Amgen Inc. $AMGN - MarketBeat
AMGN Technical Analysis | Trend, Signals & Chart Patterns | AMGEN INC (NASDAQ:AMGN) - ChartMill
Amgen Inc stock faces institutional selling pressure amid mixed 13F filings and dividend stability - AD HOC NEWS
2.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):